XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132,751 | +28.1% | 3,887 | +44.4% | 0.00% | – |
| Q2 2023 | $103,591 | +324.5% | 2,691 | +294.6% | 0.00% | – |
| Q1 2023 | $24,402 | -9.6% | 682 | +0.9% | 0.00% | – |
| Q4 2022 | $27,000 | +22.7% | 676 | +14.4% | 0.00% | – |
| Q3 2022 | $22,000 | +175.0% | 591 | +124.7% | 0.00% | – |
| Q2 2022 | $8,000 | +166.7% | 263 | +163.0% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -50.0% | 100 | -73.3% | 0.00% | – |
| Q3 2021 | $6,000 | -14.3% | 375 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | -46.2% | 375 | -50.0% | 0.00% | – |
| Q1 2021 | $13,000 | +8.3% | 750 | 0.0% | 0.00% | – |
| Q4 2020 | $12,000 | +50.0% | 750 | 0.0% | 0.00% | – |
| Q3 2020 | $8,000 | -11.1% | 750 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | 0.0% | 750 | 0.0% | 0.00% | – |
| Q1 2020 | $9,000 | – | 750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |